P. Babal et al., Regulation of ornithine decarboxylase activity and polyamine transport by agmatine in rat pulmonary artery endothelial cells, J PHARM EXP, 296(2), 2001, pp. 372-377
Citations number
37
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Agmatine, a product of arginine decarboxylation in mammalian cells, is beli
eved to govern cell polyamines by inducing antizyme, which in turn suppress
es ornithine decarboxylase (ODC) activity and polyamine uptake. However, si
nce agmatine is structurally similar to the polyamines, it is possible that
it exerts antizyme-independent actions on polyamine regulatory pathways. T
he present study determined whether agmatine inhibited ODC activity and pol
yamine transport in rat pulmonary artery endothelial cells (PAECs) by an an
tizyme-dependent mechanism. Agmatine caused time-dependent reductions in OD
C activity, which occurred before increases in antizyme. Interventions that
suppressed proteosome function caused large increases in ODC activity but
failed to attenuate inhibitory effects of agmatine. When agmatine was prese
nt in the culture medium, C-14-polyamine uptake was competitively inhibited
as evidenced by substantial elevations in Km values. If PAECs were incubat
ed with agmatine for periods sufficient to increase antizyme, there were mo
dest decreases in Vmax for putrescine and spermidine but not for spermine.
These effects of agmatine on polyamine transport were insensitive to protei
n synthesis inhibition. Collectively, our findings show that agmatine decre
ases ODC activity and polyamine transport in PAECs, but a causal role for a
ntizyme in these actions of agmatine is difficult to establish. Nevertheles
s, these observations are consistent with a model in which PAECs express bo
th antizyme-1 and -2, but only the latter contributes to agmatine-mediated
suppression of ODC activity.